)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Starsource Multitrade
Starsource Multitrade (506365) investor relations material
Starsource Multitrade Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary5 Nov, 2026
Executive summary
Board approved unaudited standalone results for the quarter ended September 30, 2026, and the half-year balance sheet and cash flow statement.
Q2 net loss was ₹622.27 thousand; the limited review included a qualified conclusion related to GST compliance records.
Financial highlights
Q2 loss before tax and net loss were each ₹622.27 thousand, versus profit of ₹209.84 thousand in Q1 and ₹980.14 thousand in Q2 FY25.
H1 net loss was ₹412.43 thousand, compared with a ₹117,070.51 thousand loss in H1 FY25; FY26 net loss was ₹118,549.73 thousand.
As at September 30, 2026, total assets were ₹18,267.34 thousand and total equity was ₹12,484.07 thousand.
H1 operating cash flow was negative ₹63.18 thousand; cash and cash equivalents at period-end were ₹57.01 thousand.
Key financial ratios and metrics
Q2 basic and diluted EPS were both negative ₹0.41; H1 EPS was negative ₹0.03, versus negative ₹78.05 in H1 FY25.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - A continuing factory lockout and Rs. 83,23,334 pre-tax loss defined the year.506365Q4 97/98
- Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365Q4 98/99
- Lockout and a widening Rs.4.38m loss drove plans to explore disposal or leasing.506365Q4 04/05
- Lockout halted operations; FY2002-03 net loss was Rs.863,221 as leasing talks continued.506365Q4 02/03
- Manufacturing ceased after asset sales; diversification and material financial risks remain.506365Q4 06/07
- Manufacturing stayed halted; FY08 PAT fell to Rs 0.08 lakh as diversification remained uncertain.506365Q4 07/08
- Suspended manufacturing, falling income and auditor-flagged asset and loan risks defined FY10.506365Q4 09/10
- A modest return to profit amid suspended operations, material audit concerns, and suspended share trading.506365Q4 10/11
Next Starsource Multitrade earnings date
Q3 26/2727 Jan, 2027
Starsource Multitrade
Next Starsource Multitrade earnings date
Q3 26/2727 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Chemo Pharma Laboratories Limited is a pharmaceutical company involved in the manufacturing and distribution of bulk drugs, intermediates, and chemical products. The company focuses on supplying raw materials used in pharmaceutical formulations and may also engage in contract manufacturing and chemical processing services. Its operations cater to pharmaceutical manufacturers and industrial clients, with an emphasis on quality compliance and regulatory standards. Chemo Pharma Laboratories Limited is headquartered in Mumbai, India, and its shares are listed on the BSE.